{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T03:53:00Z","timestamp":1785642780017,"version":"3.56.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s40618-020-01314-5","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T14:02:30Z","timestamp":1591279350000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors"],"prefix":"10.1007","volume":"44","author":[{"given":"S.","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Dolatshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-2054","authenticated-orcid":false,"given":"F.","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"issue":"10","key":"1314_CR1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.autrev.2016.07.022","volume":"15","author":"A De Virgilio","year":"2016","unstructured":"De Virgilio A, Greco A, Fabbrini G, Inghilleri M, Rizzo MI, Gallo A et al (2016) Parkinson's disease: autoimmunity and neuroinflammation. Autoimmun Rev 15(10):1005\u20131011","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1314_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"SG Reich","year":"2019","unstructured":"Reich SG, Savitt JM (2019) Parkinson's disease. Med Clin N Am 103(2):337\u2013350","journal-title":"Med Clin N Am"},{"key":"1314_CR3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12:622","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1314_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bph.12906","volume":"172","author":"JM Beaulieu","year":"2015","unstructured":"Beaulieu JM, Espinoza S, Gainetdinov RR (2015) Dopamine receptors\u2014IUPHAR review 13. Br J Pharmacol 172(1):1\u201323","journal-title":"Br J Pharmacol"},{"issue":"11","key":"1314_CR5","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0028-3908(96)00100-1","volume":"35","author":"M Jaber","year":"1996","unstructured":"Jaber M, Robinson SW, Missale C, Caron MG (1996) Dopamine receptors and brain function. Neuropharmacology 35(11):1503\u20131519","journal-title":"Neuropharmacology"},{"key":"1314_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-642-25761-2_3","volume":"212","author":"KN Boyd","year":"2012","unstructured":"Boyd KN, Mailman RB (2012) Dopamine receptor signaling and current and future antipsychotic drugs. Handb Exp Pharmacol 212:53\u201386","journal-title":"Handb Exp Pharmacol"},{"issue":"6","key":"1314_CR7","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3390\/ijerph16060950","volume":"16","author":"PM Gaum","year":"2019","unstructured":"Gaum PM, Gube M, Esser A, Schettgen T, Quinete N, Bertram J et al (2019) Depressive symptoms after PCB exposure: hypotheses for underlying pathomechanisms via the thyroid and dopamine system. Int J Environ Res Public Health 16(6):950","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"1314_CR8","doi-asserted-by":"crossref","first-page":"14633","DOI":"10.1002\/jcp.28198","volume":"234","author":"K Bavarsad","year":"2019","unstructured":"Bavarsad K, Hosseini M, Hadjzadeh MA, Sahebkar A (2019) The effects of thyroid hormones on memory impairment and Alzheimer's disease. J Cell Physiol 234(9):14633\u201314640","journal-title":"J Cell Physiol"},{"issue":"1","key":"1314_CR9","first-page":"2","volume":"11","author":"A Aranda","year":"2013","unstructured":"Aranda A, Alonso-Merino E, Zambrano A (2013) Receptors of thyroid hormones. Pediatr Endocrinol Rev PER 11(1):2\u201313","journal-title":"Pediatr Endocrinol Rev PER"},{"issue":"3\u20134","key":"1314_CR10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000359966","volume":"38","author":"SM Choi","year":"2014","unstructured":"Choi SM, Kim BC, Choi KH, Nam TS, Kim JT, Lee SH et al (2014) Thyroid status and cognitive function in euthyroid patients with early Parkinson's disease. Dement Geriatr Cogn Disord 38(3\u20134):178\u2013185","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1\u20134","key":"1314_CR11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000333222","volume":"10","author":"X Li","year":"2012","unstructured":"Li X, Sundquist J, Sundquist K (2012) Subsequent risks of Parkinson disease in patients with autoimmune and related disorders: a nationwide epidemiological study from Sweden. Neurodegener Dis 10(1\u20134):277\u2013284","journal-title":"Neurodegener Dis"},{"issue":"9","key":"1314_CR12","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603\u2013605","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"1314_CR13","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/edrv-6-4-564","volume":"6","author":"N Ben-Jonathan","year":"1985","unstructured":"Ben-Jonathan N (1985) Dopamine: a prolactin-inhibiting hormone. Endocr Rev 6(4):564\u2013589","journal-title":"Endocr Rev"},{"issue":"1","key":"1314_CR14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/gbb.12257","volume":"15","author":"G Bissonette","year":"2016","unstructured":"Bissonette G, Roesch M (2016) Development and function of the midbrain dopamine system: what we know and what we need to. Genes Brain Behav 15(1):62\u201373","journal-title":"Genes Brain Behav"},{"issue":"5","key":"1314_CR15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1515\/revneuro-2016-0068","volume":"8","author":"H Sanjari Moghaddam","year":"2017","unstructured":"Sanjari Moghaddam H, Zare-Shahabadi A, Rahmani F, Rezaei N (2017) Neurotransmission systems in Parkinson\u2019s disease. Rev Neurosci 8(5):509\u2013536","journal-title":"Rev Neurosci"},{"issue":"11","key":"1314_CR16","doi-asserted-by":"crossref","first-page":"e13861","DOI":"10.1371\/journal.pone.0013861","volume":"5","author":"I Cantuti-Castelvetri","year":"2010","unstructured":"Cantuti-Castelvetri I, Hernandez LF, Keller-McGandy CE, Kett LR, Landy A, Hollingsworth ZR et al (2010) Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats. PLoS ONE 5(11):e13861","journal-title":"PLoS ONE"},{"key":"1314_CR17","doi-asserted-by":"crossref","unstructured":"Daimon CM, Chirdon P, Maudsley S, Martin B (2013) The role of thyrotropin releasing hormone in aging and neurodegenerative diseases. Am J Alzheimer's Dis (Columbia, Mo) 1(1)","DOI":"10.7726\/ajad.2013.1003"},{"key":"1314_CR18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fncel.2018.00417","volume":"12","author":"C Zheng","year":"2018","unstructured":"Zheng C, Chen G, Tan Y, Zeng W, Peng Q, Wang J et al (2018) TRH analog, taltirelin improves motor function of hemi-PD rats without inducing dyskinesia via sustained dopamine stimulating effect. Front Cell Neurosci 12:417","journal-title":"Front Cell Neurosci"},{"issue":"6","key":"1314_CR19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/cne.24570","volume":"527","author":"O Singh","year":"2019","unstructured":"Singh O, Pradhan DR, Nagalakashmi B, Kumar S, Mitra S, Sagarkar S et al (2019) Thyrotropin-releasing hormone (TRH) in the brain and pituitary of the teleost, Clarias batrachus and its role in regulation of hypophysiotropic dopamine neurons. J Comp Neurol 527(6):1070\u20131101","journal-title":"J Comp Neurol"},{"key":"1314_CR20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3389\/fncel.2018.00485","volume":"12","author":"C Zheng","year":"2018","unstructured":"Zheng C, Chen G, Tan Y, Zeng W, Peng Q, Wang J et al (2018) TRH analog, taltirelin protects dopaminergic neurons from neurotoxicity of MPTP and rotenone. Front Cell Neurosci 12:485","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"1314_CR21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/187152711794653878","volume":"10","author":"AM Lambeir","year":"2011","unstructured":"Lambeir AM (2011) Interaction of prolyl oligopeptidase with alpha-synuclein. CNS Neurol Disord Drug Targets 10(3):349\u2013354","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"1314_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02686119","volume":"31","author":"J Goldstein","year":"2007","unstructured":"Goldstein J, Perello M, Nillni EA (2007) Preprothyrotropin-releasing hormone 178\u2013199 affects tyrosine hydroxylase biosynthesis in hypothalamic neurons. J Mol Neurosci 31(1):69\u201382","journal-title":"J Mol Neurosci"},{"issue":"2","key":"1314_CR23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/endo.142.2.7954","volume":"142","author":"EA Nillni","year":"2001","unstructured":"Nillni EA, Aird F, Seidah NG, Todd RB, Koenig JI (2001) PreproTRH178\u2013199 and two novel peptides (pFQ7 and pSE14) derived from its processing, which are produced in the paraventricular nucleus of the rat hypothalamus, are regulated during suckling**This work was supported by the National Science Foundation (Grant No. IBN-9507952 to E.A.N.). Endocrinology 142(2):896\u2013906","journal-title":"Endocrinology"},{"issue":"2","key":"1314_CR24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.yfrne.2010.01.001","volume":"31","author":"EA Nillni","year":"2010","unstructured":"Nillni EA (2010) Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs. Front Neuroendocrinol 31(2):134\u2013156","journal-title":"Front Neuroendocrinol"},{"issue":"6","key":"1314_CR25","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.beem.2009.08.003","volume":"23","author":"BR Haugen","year":"2009","unstructured":"Haugen BR (2009) Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clin Endocrinol Metab 23(6):793\u2013800","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"5","key":"1314_CR26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1590\/S1807-59322010000500013","volume":"65","author":"JC Pereira Jr","year":"2010","unstructured":"Pereira JC Jr, Pradella-Hallinan M, Pessoa HDL (2010) Imbalance between thyroid hormones and the dopaminergic system might be central to the pathophysiology of restless legs syndrome: a hypothesis. Clinics 65(5):547\u2013554","journal-title":"Clinics"},{"issue":"3","key":"1314_CR27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1210\/jcem-51-3-585","volume":"51","author":"C Feek","year":"1980","unstructured":"Feek C, Sawers J, Brown N, Seth J, Irvine W, Toft A (1980) Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion: evidence for an additional feedback mechanism in the control of thyroid hormone secretion. J Clin Endocrinol Metab 51(3):585\u2013589","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1314_CR28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.PCC.0000216680.22950.D9","volume":"7","author":"L Filippi","year":"2006","unstructured":"Filippi L, Pezzati M, Cecchi A, Poggi C (2006) Dopamine infusion: a possible cause of undiagnosed congenital hypothyroidism in preterm infants. Pediatr Crit Care Med 7(3):249\u2013251","journal-title":"Pediatr Crit Care Med"},{"issue":"2","key":"1314_CR29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000116793","volume":"32","author":"L Lestingi","year":"1992","unstructured":"Lestingi L, Bonifati V, Stocchi F, Antonozzi I, Meco G (1992) TRH test and the continuous dopaminergic stimulation in complicated Parkinson\u2019s disease. Eur Neurol 32(2):65\u201369","journal-title":"Eur Neurol"},{"issue":"6","key":"1314_CR30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000122892","volume":"28","author":"L Annunziato","year":"1979","unstructured":"Annunziato L, Di Renzo G, Schettini G, Lombardi G, Scopacasa F, Scapagnini U et al (1979) Lack of evidence for an inhibitory role played by tuberoinfundibular dopaminergic neurons on TSH secretion in the rat. Neuroendocrinology 28(6):435\u2013441","journal-title":"Neuroendocrinology"},{"issue":"11","key":"1314_CR31","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.1210\/jc.2005-1049","volume":"90","author":"FL Williams","year":"2005","unstructured":"Williams FL, Ogston SA, van Toor H, Visser TJ, Hume R (2005) Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab 90(11):5954\u20135963","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1314_CR32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.20452\/pamw.1200","volume":"122","author":"M Kobusiak-Prokopowicz","year":"2012","unstructured":"Kobusiak-Prokopowicz M, \u015aciborski K, Mysiak A (2012) Effect of intravenous dopamine infusion on pituitary and thyroid function and on nephroprotection. Pol Arch Med Wewn 122(3):82\u201388","journal-title":"Pol Arch Med Wewn"},{"issue":"3","key":"1314_CR33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1507\/endocrj1954.35.469","volume":"35","author":"T Mori","year":"1988","unstructured":"Mori T, Yokota T, Akamizu T, Inoue D, Miyamoto M, Kosugi S et al (1988) Significance of serum thyrotropin and plasma dopamine concentration in the regulation of thyroid function in elderly subjects. Endocrinol Jpn 35(3):469\u2013476","journal-title":"Endocrinol Jpn"},{"key":"1314_CR34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.psyneuen.2014.05.021","volume":"48","author":"A Mouri","year":"2014","unstructured":"Mouri A, Hoshino Y, Narusawa S, Ikegami K, Mizoguchi H, Murata Y et al (2014) Thyrotoropin receptor knockout changes monoaminergic neuronal system and produces methylphenidate-sensitive emotional and cognitive dysfunction. Psychoneuroendocrinology 48:147\u2013161","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"1314_CR35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/endo-118-2-632","volume":"118","author":"ML Maayan","year":"1986","unstructured":"Maayan ML, Sellitto RV, Volpert EM (1986) Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release. Endocrinology 118(2):632\u2013636","journal-title":"Endocrinology"},{"issue":"8","key":"1314_CR36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3109\/14767058.2014.937696","volume":"28","author":"S Ekmen","year":"2015","unstructured":"Ekmen S, Degirmencioglu H, Uras N, Oncel MY, Sari FN, Canpolat FE et al (2015) Effect of dopamine infusion on thyroid hormone tests and prolactin levels in very low birth weight infants. J Matern Fetal Neonatal Med 28(8):924\u2013927","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"4","key":"1314_CR37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijdevneu.2013.02.001","volume":"31","author":"WA Hassan","year":"2013","unstructured":"Hassan WA, Aly MS, Rahman TA, Shahat AS (2013) Impact of experimental hypothyroidism on monoamines level in discrete brain regions and other peripheral tissues of young and adult male rats. Int J Dev Neurosci 31(4):225\u2013233","journal-title":"Int J Dev Neurosci"},{"issue":"4","key":"1314_CR38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0091-3057(84)80040-4","volume":"21","author":"DH Overstreet","year":"1984","unstructured":"Overstreet DH, Crocker AD, Lawson CA, McIntosh GH, Crocker JM (1984) Alterations in the dopaminergic system and behaviour in rats reared on iodine-deficient diets. Pharmacol Biochem Behav 21(4):561\u2013565","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"1314_CR39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0165-3806(85)90058-6","volume":"23","author":"J Puymirat","year":"1985","unstructured":"Puymirat J, Faivre-Bauman A, Barret A, Loudes C, Tixier-Vidal A (1985) Does triiodothyronine influence the morphogenesis of fetal mouse mesencephalic dopaminergic neurons cultured in chemically defined medium? Dev Brain Res 23(2):315\u2013317","journal-title":"Dev Brain Res"},{"issue":"1","key":"1314_CR40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000124797","volume":"46","author":"MJ Reymond","year":"1987","unstructured":"Reymond MJ, Benotto W, Lemarchand-Beraud T (1987) The secretory activity of the tuberoinfundibular dopaminergic neurons is modulated by the thyroid status in the adult rat: consequence on prolactin secretion. Neuroendocrinology 46(1):62\u201368","journal-title":"Neuroendocrinology"},{"issue":"3","key":"1314_CR41","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/jne.12135","volume":"26","author":"N Shimokawa","year":"2014","unstructured":"Shimokawa N, Yousefi B, Morioka S, Yamaguchi S, Ohsawa A, Hayashi H et al (2014) Altered cerebellum development and dopamine distribution in a rat genetic model with congenital hypothyroidism. J Neuroendocrinol 26(3):164\u2013175","journal-title":"J Neuroendocrinol"},{"issue":"12","key":"1314_CR42","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1365-2826.2005.01381.x","volume":"17","author":"A Oh-Nishi","year":"2005","unstructured":"Oh-Nishi A, Saji M, Furudate SI, Suzuki N (2005) Dopamine D2-like receptor function is converted from excitatory to inhibitory by thyroxine in the developmental hippocampus. J Neuroendocrinol 17(12):836\u2013845","journal-title":"J Neuroendocrinol"},{"issue":"1","key":"1314_CR43","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1365-2826.2007.01622.x","volume":"20","author":"S Schaefer","year":"2008","unstructured":"Schaefer S, Vogt T, Nowak T, Kann PH (2008) Pituitary function and the somatotrophic system in patients with idiopathic Parkinson's disease under chronic dopaminergic therapy. J Neuroendocrinol 20(1):104\u2013109","journal-title":"J Neuroendocrinol"},{"issue":"6","key":"1314_CR44","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2004.03.008","volume":"10","author":"RP Munhoz","year":"2004","unstructured":"Munhoz RP, Teive HA, Troiano AR, Hauck PCR, Leiva MHH, Graff H et al (2004) Parkinson's disease and thyroid dysfunction. Parkinsonism Relat Disord 10(6):381\u2013383","journal-title":"Parkinsonism Relat Disord"},{"issue":"1\u20132","key":"1314_CR45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1353-8020(99)00010-3","volume":"5","author":"U Bonuccelli","year":"1999","unstructured":"Bonuccelli U, D'Avino C, Caraccio N, Del Guerra P, Casolaro A, Pavese N et al (1999) Thyroid function and autoimmunity in Parkinson's disease: a study of 101 patients. Parkinsonism Relat Disord 5(1\u20132):49\u201353","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1314_CR46","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbadis.2011.11.008","volume":"1822","author":"M Vairetti","year":"2012","unstructured":"Vairetti M, Ferrigno A, Rizzo V, Ambrosi G, Bianchi A, Richelmi P et al (2012) Impaired hepatic function and central dopaminergic denervation in a rodent model of Parkinson's disease: a self-perpetuating crosstalk? Biochim Biophys Acta BBA Mol Basis Dis 1822(2):176\u2013184","journal-title":"Biochim Biophys Acta BBA Mol Basis Dis"},{"issue":"6","key":"1314_CR47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2826.2011.02134.x","volume":"23","author":"N Aziz","year":"2011","unstructured":"Aziz N, Pijl H, Fr\u00f6lich M, Roelfsema F, Roos R (2011) Diurnal secretion profiles of growth hormone, thyrotrophin and prolactin in Parkinson\u2019s disease. J Neuroendocrinol 23(6):519\u2013524","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"1314_CR48","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s00415-015-7780-x","volume":"262","author":"T Umehara","year":"2015","unstructured":"Umehara T, Matsuno H, Toyoda C, Oka H (2015) Thyroid hormone level is associated with motor symptoms in de novo Parkinson\u2019s disease. J Neurol 262(7):1762\u20131768","journal-title":"J Neurol"},{"issue":"2","key":"1314_CR49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.etap.2012.12.008","volume":"35","author":"M Salama","year":"2013","unstructured":"Salama M, Helmy B, El-Gamal M, Reda A, Ellaithy A, Tantawy D et al (2013) Role of L-thyroxin in counteracting rotenone induced neurotoxicity in rats. Environ Toxicol Pharmacol 35(2):270\u2013277","journal-title":"Environ Toxicol Pharmacol"},{"issue":"6","key":"1314_CR50","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1523\/JNEUROSCI.21-06-02028.2001","volume":"21","author":"FR Lima","year":"2001","unstructured":"Lima FR, Gervais A, Colin C, Izembart M, Neto VM, Mallat M (2001) Regulation of microglial development: a novel role for thyroid hormone. J Neurosci 21(6):2028\u20132038","journal-title":"J Neurosci"},{"issue":"5","key":"1314_CR51","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000116972","volume":"33","author":"M Kihara","year":"1993","unstructured":"Kihara M, Kihara Y, Tukamoto T, Nishimura Y, Watanabe H, Hanakago R et al (1993) Assessment of sudomotor dysfunction in early Parkinson's disease. Eur Neurol 33(5):363\u2013365","journal-title":"Eur Neurol"},{"issue":"8","key":"1314_CR52","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1212\/WNL.58.8.1247","volume":"58","author":"D Goldstein","year":"2002","unstructured":"Goldstein D, Holmes C, Dendi R, Bruce S, Li S-T (2002) Orthostatic hypotension from sympathetic denervation in Parkinson\u2019s disease. Neurology 58(8):1247\u20131255","journal-title":"Neurology"},{"key":"1314_CR53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fnins.2017.00375","volume":"11","author":"H Hotta","year":"2017","unstructured":"Hotta H, Onda A, Suzuki H, Milliken P, Sridhar A (2017) Modulation of calcitonin, parathyroid hormone, and thyroid hormone secretion by electrical stimulation of sympathetic and parasympathetic nerves in anesthetized rats. Front Neurosci 11:375","journal-title":"Front Neurosci"},{"issue":"4","key":"1314_CR54","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1210\/endo-94-4-959","volume":"94","author":"A Melander","year":"1974","unstructured":"Melander A, Ericson L, Sundler F, Ingbar S (1974) Sympathetic innervation of the mouse thyroid and its significance in thyroid hormone secretion. Endocrinology 94(4):959\u2013966","journal-title":"Endocrinology"},{"issue":"1","key":"1314_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2009.09.005","volume":"44","author":"V Stolakis","year":"2010","unstructured":"Stolakis V, Kalafatakis K, Botis J, Zarros A, Liapi C (2010) The regulatory role of neurotensin on the hypothalamic\u2013anterior pituitary axons: emphasis on the control of thyroid-related functions. Neuropeptides 44(1):1\u20137","journal-title":"Neuropeptides"},{"issue":"4","key":"1314_CR56","first-page":"229","volume":"31","author":"F St-Gelais","year":"2006","unstructured":"St-Gelais F, Jomphe C, Trudeau L-\u00c9 (2006) The role of neurotensin in central nervous system pathophysiology: what is the evidence? J Psychiatry Neurosci 31(4):229\u2013245","journal-title":"J Psychiatry Neurosci"},{"issue":"3","key":"1314_CR57","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/ijms18030551","volume":"18","author":"R Cacabelos","year":"2017","unstructured":"Cacabelos R (2017) Parkinson's disease: from pathogenesis to pharmacogenomics. Int J Mol Sci 18(3):551","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1314_CR58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/WNL.31.1.93","volume":"31","author":"JR Berger","year":"1981","unstructured":"Berger JR, Kelley RE (1981) Thyroid function in Parkinson disease. Neurology 31(1):93\u201395","journal-title":"Neurology"},{"issue":"2","key":"1314_CR59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000123369","volume":"35","author":"L Krulich","year":"1982","unstructured":"Krulich L (1982) Neurotransmitter control of thyrotropin secretion. Neuroendocrinology 35(2):139\u2013147","journal-title":"Neuroendocrinology"},{"issue":"12","key":"1314_CR60","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/jnnp.55.12.1210-a","volume":"55","author":"B Verg\u00e8s","year":"1992","unstructured":"Verg\u00e8s B, Giroud M, Vaillant G, Verges-Patois B, Brun J, Putelat R (1992) Ultrasensitive TSH assay and anti-parkinsonian treatment with levodopa. J Neurol Neurosurg Psychiatry 55(12):1210","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1314_CR61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2019.05.004","volume":"855","author":"S Pourmirbabaei","year":"2019","unstructured":"Pourmirbabaei S, Dolatshahi M, Rahmani F (2019) Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia. Eur J Pharmacol 855:149\u2013159","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1314_CR62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0404.1991.tb04666.x","volume":"83","author":"G Cusimano","year":"1991","unstructured":"Cusimano G, Capriani C, Bonifati V, Meco G (1991) Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients. Acta Neurol Scand 83(3):145\u2013150","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"1314_CR63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000117588","volume":"3","author":"A Polleri","year":"1977","unstructured":"Polleri A, Carolei A, Rolandi E, Masturzo P, Meco G, Agnoli A (1977) Changes in pituitary hormones serum levels in bromocryptine-treated parkinsonian patients. Neuropsychobiology 3(1):42\u201348","journal-title":"Neuropsychobiology"},{"key":"1314_CR64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.parkreldis.2020.04.001","volume":"74","author":"SF Chen","year":"2020","unstructured":"Chen SF, Yang YC, Hsu CY, Shen YC (2020) Risk of Parkinson's disease in patients with hypothyroidism: a nationwide population-based cohort study. Parkinsonism Relat Disord 74:28\u201332","journal-title":"Parkinsonism Relat Disord"},{"issue":"15","key":"1314_CR65","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1089\/ars.2014.6072","volume":"21","author":"E Fern\u00e1ndez","year":"2014","unstructured":"Fern\u00e1ndez E, Garc\u00eda-Moreno JM, de Pablos MA, Chac\u00f3n J (2014) May the thyroid gland and thyroperoxidase participate in nitrosylation of serum proteins and sporadic Parkinson's disease? Antioxidants Redox Signal 21(15):2143\u20132148","journal-title":"Antioxidants Redox Signal"},{"issue":"3","key":"1314_CR66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0167-4943(01)00196-0","volume":"33","author":"H Tandeter","year":"2001","unstructured":"Tandeter H, Levy A, Gutman G, Shvartzman P (2001) Subclinical thyroid disease in patients with Parkinson's disease. Arch Gerontol Geriatr 33(3):295\u2013300","journal-title":"Arch Gerontol Geriatr"},{"issue":"6","key":"1314_CR67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.parkreldis.2004.03.008","volume":"10","author":"RP Munhoz","year":"2004","unstructured":"Munhoz RP, Teive HA, Troiano AR, Hauck PR, Herdoiza Leiva MH, Graff H et al (2004) Parkinson's disease and thyroid dysfunction. Parkinsonism Relat Disord 10(6):381\u2013383","journal-title":"Parkinsonism Relat Disord"},{"key":"1314_CR68","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bbr.2019.03.027","volume":"366","author":"ME da Cunha","year":"2019","unstructured":"da Cunha ME, dos Santos PR, Goes TC, de Carvalho VCB, Teixeira-Silva F, Stevens HE et al (2019) Effects of a rat model of gestational hypothyroidism on forebrain dopaminergic, gabaergic, and serotonergic systems and related behaviors. Behav Brain Res 366:77\u201387","journal-title":"Behav Brain Res"},{"issue":"10101","key":"1314_CR69","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","volume":"390","author":"L Chaker","year":"2017","unstructured":"Chaker L, Bianco AC, Jonklaas J, Peeters RP (2017) Hypothyroidism. Lancet (Lond Engl) 390(10101):1550\u20131562","journal-title":"Lancet (Lond Engl)"},{"key":"1314_CR70","first-page":"91","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson's disease. Front Neuroanat 9:91","journal-title":"Front Neuroanat"},{"key":"1314_CR71","doi-asserted-by":"crossref","first-page":"6757154","DOI":"10.1155\/2016\/6757154","volume":"2016","author":"A Mancini","year":"2016","unstructured":"Mancini A, Di Segni C, Raimondo S, Olivieri G, Silvestrini A, Meucci E et al (2016) Thyroid hormones, oxidative stress, and inflammation. Mediat Inflamm 2016:6757154","journal-title":"Mediat Inflamm"},{"issue":"5","key":"1314_CR72","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4103\/2230-8210.190555","volume":"20","author":"SK Chakrabarti","year":"2016","unstructured":"Chakrabarti SK, Ghosh S, Banerjee S, Mukherjee S, Chowdhury S (2016) Oxidative stress in hypothyroid patients and the role of antioxidant supplementation. Indian J Endocrinol Metab 20(5):674\u2013678","journal-title":"Indian J Endocrinol Metab"},{"key":"1314_CR73","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1677\/joe.0.1760031","volume":"176","author":"N Petrovic","year":"2003","unstructured":"Petrovic N, Cvijic G, Davidovi\u0107 V (2003) Thyroxine and tri-iodothyronine differently affect uncoupling protein-1 content and antioxidant enzyme activities in rat interscapular brown adipose tissue. J Endocrinol 176:31\u201338","journal-title":"J Endocrinol"},{"key":"1314_CR74","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1677\/joe.0.1550151","volume":"155","author":"P Venditti","year":"1997","unstructured":"Venditti P, Balestrieri M, Di Meo S, Leo T (1997) Effect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues. J Endocrinol 155:151\u2013157","journal-title":"J Endocrinol"},{"issue":"4","key":"1314_CR75","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4103\/2230-8210.183454","volume":"20","author":"D Sanyal","year":"2016","unstructured":"Sanyal D, Raychaudhuri M (2016) Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab 20(4):554\u2013557","journal-title":"Indian J Endocrinol Metab"},{"issue":"Suppl 1","key":"1314_CR76","first-page":"40","volume":"5","author":"S Longhi","year":"2013","unstructured":"Longhi S, Radetti G (2013) Thyroid function and obesity. J Clin Res Pediatr Endocrinol 5(Suppl 1):40\u201344","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"9","key":"1314_CR77","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1007\/s12035-016-0193-8","volume":"54","author":"CA Martin-Jimenez","year":"2017","unstructured":"Martin-Jimenez CA, Gaitan-Vaca DM, Echeverria V, Gonzalez J, Barreto GE (2017) Relationship between obesity, Alzheimer's disease, and Parkinson's disease: an astrocentric view. Mol Neurobiol 54(9):7096\u20137115","journal-title":"Mol Neurobiol"},{"key":"1314_CR78","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.brainres.2019.04.013","volume":"1718","author":"S Mohammadi","year":"2019","unstructured":"Mohammadi S, Dolatshahi M, Zare-Shahabadi A, Rahmani F (2019) Untangling narcolepsy and diabetes: pathomechanisms with eyes on therapeutic options. Brain Res 1718:212\u2013222","journal-title":"Brain Res"},{"key":"1314_CR79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lfs.2017.06.002","volume":"182","author":"JN Mazon","year":"2017","unstructured":"Mazon JN, de Mello AH, Ferreira GK, Rezin GT (2017) The impact of obesity on neurodegenerative diseases. Life Sci 182:22\u201328","journal-title":"Life Sci"},{"key":"1314_CR80","doi-asserted-by":"crossref","first-page":"439463","DOI":"10.4061\/2011\/439463","volume":"2011","author":"M Hage","year":"2011","unstructured":"Hage M, Zantout MS, Azar ST (2011) Thyroid disorders and diabetes mellitus. J Thyroid Res 2011:439463","journal-title":"J Thyroid Res"},{"issue":"4","key":"1314_CR81","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2337\/dc06-2011","volume":"30","author":"G Hu","year":"2007","unstructured":"Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J (2007) Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30(4):842","journal-title":"Diabetes Care"},{"issue":"19","key":"1314_CR82","doi-asserted-by":"crossref","first-page":"e1654","DOI":"10.1212\/WNL.0000000000005475","volume":"90","author":"G Pagano","year":"2018","unstructured":"Pagano G, Polychronis S, Wilson H, Giordano B, Ferrara N, Niccolini F et al (2018) Diabetes mellitus and Parkinson disease. Neurology 90(19):e1654\u2013e1662","journal-title":"Neurology"},{"issue":"3","key":"1314_CR83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3233\/JPD-171103","volume":"7","author":"C Galvagnion","year":"2017","unstructured":"Galvagnion C (2017) The role of lipids interacting with alpha-synuclein in the pathogenesis of Parkinson's disease. J Parkinson's Dis 7(3):433\u2013450","journal-title":"J Parkinson's Dis"},{"key":"1314_CR84","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.freeradbiomed.2016.10.008","volume":"101","author":"M Doria","year":"2016","unstructured":"Doria M, Maugest L, Moreau T, Lizard G, Vejux A (2016) Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease. Free Radic Biol Med 101:393\u2013400","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1314_CR85","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/pds.4079","volume":"26","author":"K Bykov","year":"2017","unstructured":"Bykov K, Yoshida K, Weisskopf MG, Gagne JJ (2017) Confounding of the association between statins and Parkinson disease: systematic review and meta-analysis. Pharmacoepidemiol Drug Saf 26(3):294\u2013300","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1314_CR86","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00415-017-8403-5","volume":"264","author":"F Rahmani","year":"2017","unstructured":"Rahmani F, Aarabi MH (2017) Does apolipoprotein A1 predict microstructural changes in subgenual cingulum in early Parkinson? J Neurol 264(4):684\u2013693","journal-title":"J Neurol"},{"issue":"3","key":"1314_CR87","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cvr\/cvu148","volume":"103","author":"C Vitali","year":"2014","unstructured":"Vitali C, Wellington CL, Calabresi L (2014) HDL and cholesterol handling in the brain. Cardiovasc Res 103(3):405\u2013413","journal-title":"Cardiovasc Res"},{"issue":"10","key":"1314_CR88","first-page":"1712","volume":"45","author":"Y Krausz","year":"2004","unstructured":"Krausz Y, Freedman N, Lester H, Newman JP, Barkai G, Bocher M et al (2004) Regional cerebral blood flow in patients with mild hypothyroidism. J Nucl Med 45(10):1712\u20131715","journal-title":"J Nucl Med"},{"issue":"3","key":"1314_CR89","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/EJE-11-0254","volume":"165","author":"U Utku","year":"2011","unstructured":"Utku U, Gokce M, Ozkaya M (2011) Changes in cerebral blood flow velocity in patients with hypothyroidism. Eur J Endocrinol 165(3):465\u2013468","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1314_CR90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola C (2017) The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron 96(1):17\u201342","journal-title":"Neuron"},{"key":"1314_CR91","doi-asserted-by":"crossref","first-page":"29651","DOI":"10.1038\/srep29651","volume":"6","author":"CT Hong","year":"2016","unstructured":"Hong CT, Huang YH, Liu HY, Chiou HY, Chan L, Chien LN (2016) Newly diagnosed anemia increases risk of Parkinson's disease: a population-based cohort study. Sci Rep 6:29651","journal-title":"Sci Rep"},{"key":"1314_CR92","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fnagi.2017.00394","volume":"9","author":"JA Santiago","year":"2017","unstructured":"Santiago JA, Bottero V, Potashkin JA (2017) Biological and clinical implications of comorbidities in Parkinson's disease. Front Aging Neurosci 9:394","journal-title":"Front Aging Neurosci"},{"issue":"4","key":"1314_CR93","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3233\/JPD-130197","volume":"3","author":"NP Visanji","year":"2013","unstructured":"Visanji NP, Collingwood JF, Finnegan ME, Tandon A, House E, Hazrati LN (2013) Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy. J Parkinson's Dis 3(4):523\u2013537","journal-title":"J Parkinson's Dis"},{"issue":"5","key":"1314_CR94","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.3892\/mmr.2017.6386","volume":"15","author":"G Mostile","year":"2017","unstructured":"Mostile G, Cicero CE, Giuliano L, Zappia M, Nicoletti A (2017) Iron and Parkinson's disease: a systematic review and meta-analysis. Mol Med Rep 15(5):3383\u20133389","journal-title":"Mol Med Rep"},{"issue":"5","key":"1314_CR95","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10072-017-2839-3","volume":"38","author":"G Defazio","year":"2017","unstructured":"Defazio G, Esposito M, Abbruzzese G, Scaglione CL, Fabbrini G, Ferrazzano G et al (2017) The Italian Dystonia Registry: rationale, design and preliminary findings. Neurol Sci 38(5):819\u2013825","journal-title":"Neurol Sci"},{"issue":"6538","key":"1314_CR96","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bmj.293.6538.38","volume":"293","author":"T Caradoc-Davies","year":"1986","unstructured":"Caradoc-Davies T (1986) Resolution of dyskinesia and the\" on-off\" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment. Br Med J (Clin Res Ed) 293(6538):38","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"5","key":"1314_CR97","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.parkreldis.2005.01.009","volume":"11","author":"HT Kim","year":"2005","unstructured":"Kim HT, Edwards MJ, Narsimhan RL, Bhatia KP (2005) Hyperthyroidism exaggerating parkinsonian tremor: a clinical lesson. Parkinsonism Relat Disord 11(5):331\u2013332","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1314_CR98","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF03343841","volume":"24","author":"J Davies","year":"2001","unstructured":"Davies J, Morrish P, Scanlon M (2001) Graves\u2019 disease presenting as hemiparkinsonism. J Endocrinol Investig 24(3):188\u2013189","journal-title":"J Endocrinol Investig"},{"issue":"17","key":"1314_CR99","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1007\/s00018-012-1217-9","volume":"70","author":"P Venditti","year":"2013","unstructured":"Venditti P, Di Stefano L, Di Meo S (2013) Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues. Cell Mol Life Sci 70(17):3125\u20133144","journal-title":"Cell Mol Life Sci"},{"key":"1314_CR100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","volume":"385","author":"JF Baizabal-Carvallo","year":"2018","unstructured":"Baizabal-Carvallo JF, Jankovic J (2018) Autoimmune and paraneoplastic movement disorders: an update. J Neurol Sci 385:175\u2013184","journal-title":"J Neurol Sci"},{"issue":"3","key":"1314_CR101","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/ane.12618","volume":"135","author":"JY Zhou","year":"2017","unstructured":"Zhou JY, Xu B, Lopes J, Blamoun J, Li L (2017) Hashimoto encephalopathy: literature review. Acta Neurol Scand 135(3):285\u2013290","journal-title":"Acta Neurol Scand"},{"issue":"23","key":"1314_CR102","first-page":"3611","volume":"18","author":"YH Dong","year":"2014","unstructured":"Dong YH, Fu DG (2014) Autoimmune thyroid disease: mechanism, genetics and current knowledge. Eur Rev Med Pharmacol Sci 18(23):3611\u20133618","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"1314_CR103","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1097\/RLU.0000000000001728","volume":"42","author":"J Otsuka","year":"2017","unstructured":"Otsuka J, Hida A, Ogyu K, Minamimoto R, Takeuchi S (2017) Improved 123I-Ioflupane binding after immunotherapy in anti-NAE antibody-positive hashimoto encephalopathy that clinically mimicked multiple system atrophy. Clin Nucl Med 42(8):e390\u2013e391","journal-title":"Clin Nucl Med"},{"key":"1314_CR104","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2202-4-25","volume":"4","author":"H Barbas","year":"2003","unstructured":"Barbas H, Saha S, Rempel-Clower N, Ghashghaei T (2003) Serial pathways from primate prefrontal cortex to autonomic areas may influence emotional expression. BMC Neurosci 4:25","journal-title":"BMC Neurosci"},{"issue":"1","key":"1314_CR105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11910-017-0709-2","volume":"17","author":"JA Honorat","year":"2017","unstructured":"Honorat JA, McKeon A (2017) Autoimmune movement disorders: a clinical and laboratory approach. Curr Neurol Neurosci Rep 17(1):4","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1314_CR106","doi-asserted-by":"crossref","unstructured":"Jankovic J (2018) Immunologic treatment of Parkinson's disease. Future Med","DOI":"10.2217\/imt-2017-0146"},{"key":"1314_CR107","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.parkreldis.2018.06.008","volume":"55","author":"M Miranda","year":"2018","unstructured":"Miranda M, Bustamante ML, Campero M, Wainstein E, Toche P, Espay AJ et al (2018) Movement disorders in non-encephalopathic Hashimoto's thyroiditis. Parkinsonism Relat Disord 55:141\u2013142","journal-title":"Parkinsonism Relat Disord"},{"key":"1314_CR108","unstructured":"Fauzi NAM, Abdullah S, Tan AH, Ramli NM, Tan CY, Lim S-Y (2019) Relapsing encephalopathy with dancing eyes and jerky limbs. Parkinsonism Relat Disord"},{"issue":"1","key":"1314_CR109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ncl.2014.09.014","volume":"33","author":"O Waln","year":"2015","unstructured":"Waln O, Jankovic J (2015) Paroxysmal movement disorders. Neurol Clin 33(1):137\u2013152","journal-title":"Neurol Clin"},{"issue":"4","key":"1314_CR110","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4103\/0976-3147.120226","volume":"4","author":"AQ Rana","year":"2013","unstructured":"Rana AQ, Nadeem A, Yousuf MS, Kachhvi ZM (2013) Late onset of atypical paroxysmal non-kinesigenic dyskinesia with remote history of Graves' disease. J Neurosci Rural Pract 4(4):449\u2013450","journal-title":"J Neurosci Rural Pract"},{"key":"1314_CR111","doi-asserted-by":"crossref","unstructured":"Delhasse S, Debove I, Arnold-Kunz G, Ghika JA, Chabwine JN (2019) Erratic movement disorders disclosing Graves' disease and paralleling thyroid function but not autoantibody levels. J Int Med Res","DOI":"10.1177\/0300060518816873"},{"issue":"5","key":"1314_CR112","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/ana.410170514","volume":"17","author":"B Jansson","year":"1985","unstructured":"Jansson B, Jankovic J (1985) Low cancer rates among patients with Parkinson's disease. Ann Neurol 17(5):505\u2013509","journal-title":"Ann Neurol"},{"key":"1314_CR113","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.parkreldis.2016.04.028","volume":"28","author":"C Peretz","year":"2016","unstructured":"Peretz C, Gurel R, Rozani V, Gurevich T, El-Ad B, Tsamir J et al (2016) Cancer incidence among Parkinson's disease patients in a 10-yrs time-window around disease onset: a large-scale cohort study. Parkinsonism Relat Disord 28:68\u201372","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1314_CR114","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.gtc.2009.06.003","volume":"38","author":"IJ Cook","year":"2009","unstructured":"Cook IJ (2009) Oropharyngeal dysphagia. Gastroenterol Clin N Am 38(3):411\u2013431","journal-title":"Gastroenterol Clin N Am"},{"key":"1314_CR115","doi-asserted-by":"crossref","unstructured":"Napolitano F, D'Angelo L, de Girolamo P, Avallone L, de Lange P, Usiello A (2018) The Thyroid-target gene Rhes, a novel crossroad for neurological and psychiatric disorders: new insights from animal models. Neuroscience","DOI":"10.1016\/j.neuroscience.2018.05.027"},{"issue":"1","key":"1314_CR116","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12929-016-0270-3","volume":"23","author":"M Haque","year":"2016","unstructured":"Haque M, Kendal JK, MacIsaac RM, Demetrick DJ (2016) WSB1: from homeostasis to hypoxia. J Biomed Sci 23(1):61","journal-title":"J Biomed Sci"},{"issue":"2","key":"1314_CR117","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI77588","volume":"125","author":"WJP de Castro","year":"2015","unstructured":"de Castro WJP, Fonseca TL, Ueta CB, McAninch EA, Abdalla S, Wittmann G et al (2015) Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine. J Clin Investig 125(2):769\u2013781","journal-title":"J Clin Investig"},{"issue":"2","key":"1314_CR118","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/mcne.2002.1131","volume":"20","author":"A Cuadrado","year":"2002","unstructured":"Cuadrado A, Garc\u0131\u0301a-Fern\u00e1ndez LF, Imai T, Okano H, Mu\u00f1oz A, (2002) Regulation of tau RNA maturation by thyroid hormone is mediated by the neural RNA-binding protein musashi-1. Mol Cell Neurosci 20(2):198\u2013210","journal-title":"Mol Cell Neurosci"},{"key":"1314_CR119","doi-asserted-by":"crossref","unstructured":"Lambeth JD, Krause K-H, Clark RA (eds) (2008) NOX enzymes as novel targets for drug development. Seminars in immunopathology. Springer, New York","DOI":"10.1007\/s00281-008-0123-6"},{"issue":"4","key":"1314_CR120","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0306-4522(96)00091-7","volume":"72","author":"O Bandmann","year":"1996","unstructured":"Bandmann O, Davis M, Mrasden C, Wood N (1996) The human homologue of the weaver mouse gene in familial and sporadic Parkinson's disease. Neuroscience 72(4):877\u2013879","journal-title":"Neuroscience"},{"issue":"2","key":"1314_CR121","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/exnr.1999.7231","volume":"160","author":"M Blum","year":"1999","unstructured":"Blum M, Weickert C, Carrasco E (1999) The weaver GIRK2 mutation leads to decreased levels of serum thyroid hormone: characterization of the effect on midbrain dopaminergic neuron survival. Exp Neurol 160(2):413\u2013424","journal-title":"Exp Neurol"},{"issue":"1","key":"1314_CR122","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-9-47","volume":"9","author":"J-Q Li","year":"2014","unstructured":"Li J-Q, Tan L, Yu J-T (2014) The role of the LRRK2 gene in Parkinsonism. Mol Neurodegener 9(1):47","journal-title":"Mol Neurodegener"},{"issue":"4","key":"1314_CR123","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1073\/pnas.1012500108","volume":"108","author":"BD Looyenga","year":"2011","unstructured":"Looyenga BD, Furge KA, Dykema KJ, Koeman J, Swiatek PJ, Giordano TJ et al (2011) Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas. Proc Natl Acad Sci USA 108(4):1439\u20131444","journal-title":"Proc Natl Acad Sci USA"},{"key":"1314_CR124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2013.01.011","volume":"537","author":"EM Gatto","year":"2013","unstructured":"Gatto EM, Parisi V, Converso DP, Poderoso JJ, Carreras MC, Mart\u00ed-Mass\u00f3 JF et al (2013) The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics. Neurosci Lett 537:1\u20135","journal-title":"Neurosci Lett"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01314-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01314-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01314-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T23:10:29Z","timestamp":1722985829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01314-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":124,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01314-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"7 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any study with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}